𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis

✍ Scribed by Maetzel, Andreas ;Krahn, Murray ;Naglie, Gary


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
122 KB
Volume
49
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A cost-effectiveness analysis of treatme
✍ Hyon K. Choi; John D. Seeger; Karen M. Kuntz πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce

Tuberculosis infection in patients with
✍ Frederick Wolfe; Kaleb Michaud; Janice Anderson; Kathy Urbansky πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 2 views

## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions